Triptolide Protects Podocytes from Angiotensin II Induced Injury in Vitro

Fei Liu

2010-01-01

Abstract:Objective:To investigate whether tripotolide have direct effect on podocyte injured by Ang Ⅱ ? If so,how does it work? Methodology:The heat-sensitive mouse podocytes were divided into three groups:negative control,positive control treated with Ang Ⅱ (10-6,10-7,10-8mol/L) and pretreated with triptolide (1,3,10 ng/ml) for 2 hours. F-actin and zonula occludens-1 (ZO-1) were observed by fluorescence microscopy. To explore the underlying mechanism,we observed reactive oxygen species (ROS) generation and the subsequent MAPK activation by flow cytometry and western blot. Results:Ang Ⅱ induced actin cytoskeleton reorganization and ZO-1 redistribution in a dose-dependent manner. In untreated podocytes,the ZO-1 staining was peripherally distributed at contacts of adjacent cells as fine segments,while it appeared markedly fragmented in response Ang Ⅱ,indicating tight junction loose and cell ruffling. Triptolide stabilized actin filaments and improved ZO-1 distribution in a dose dependent manner. At the dose of 10 ng/ml,triptolide almost completely restored the normal cytoskeleton and cell contact in podocyte without affecting cell survival. Ang Ⅱ (10-7mol/L) significantly increased ROS generation in podocyte. This effect was observed rapidly at 10 min and maintained for 30 min. Pretreatment of podocyte with triptolide (10 ng/ml) or antioxidant NAC (10 mmol/L) before Ang Ⅱ exposure led to a significant reduction in the cellular ROS level. In addition,antioxidant NAC successfully reduced Ang Ⅱ-induced podocyte damage as showed by cytoskeleton staining,indicating that ROS generation mediates Ang-induced podocyte injury. Furthermore,triptolide effectively inhibited Ang Ⅱ-induced p-38,ERK1/2 and JNK MAPK activation,which are the downstream signaling molecules of ROS. SB203580 and U0126,which are specific kinase inhibitor for p-38 and ERK MAPK,can block Ang Ⅱ induced podocyte injury. Conclusion:Triptolide showed dramatic protective effect in Ang Ⅱ induced podocyte injury. The protective effect of triptolide might partially contribute to the inhibition of ROS generation and the subsequent MAPK activation.